Avia Pharma AB
Alexandra Palmqvist is an experienced professional in regulatory affairs and quality management, currently serving as the Director of Regulatory Affairs and Quality at Avia Pharma AB since October 2020. In this role, Alexandra oversees regulatory strategies, submissions, quality management system development, and compliance with regulations while contributing to business development and conducting due diligence for mergers and acquisitions. As Chairman of the Board for the Regulatory Affairs section at Apotekarsocieteten since January 2018, Alexandra leads the section's activities, manages budgets, plans networking events, and develops educational courses. Previous roles include Nordic Life Cycle and Portfolio Manager and Regulatory Affairs Manager at Mylan, as well as a Regulatory CMC Associate at AstraZeneca and laboratory technician positions at KTH and Karolinska University Hospital. Alexandra holds a Master of Science degree in Biotechnology from KTH Royal Institute of Technology.
This person is not in any teams
This person is not in any offices
Avia Pharma AB
We work in the most important field there is – health. It’s absolutely fundamental in order to experience and enjoy all aspects of life. With this belief at the core, the company was founded by senior executives in 2016. Since then we have grown rapidly and during 2020 we passed 20 million EUR in sales. We operate in all Nordic countries and focus on four therapy areas: women’s health, urology, dermatology and OTC. Currently we have over 20 products in our portfolio – a combination of our own as well as in-licensed pharmaceuticals from international companies like Endoceutics, Perrigo, Menarini and Dr Pfleger.